If You’re A Risk-Taking Investor, Standard BioTools Inc (NASDAQ: LAB) Is Worth Taking A Chance On.
In the last trading session, 1.8 million shares of the Standard BioTools Inc (NASDAQ:LAB) were traded, and its beta was 1.56. Most recently the company’s